Skip to main content

New, free course on capturing the value of V1C for healthcare!

Join FDA and DiMe during a 2-day virtual event.

DiMe Publications

Considerations for Analyzing and Interpreting Data from Biometric Monitoring Technologies in Clinical Trials

DiMe Research Committee working group discusses key considerations for generating evidence for clinical validity, regulatory pathways through which clinical validity evidence may be reviewed, and challenges that investigators may encounter while dealing with data from biometric monitoring technologies.


Join our next project

Help streamline the path to regulatory and commercial success to optimize health outcomes for the greatest number of patients

Join the Integrated Evidence Plans project

Join us
Not today